This inventor holds 2 USPTO granted patents. Top assignee: Northwestern University. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Evanston, IL (US) (2012)
- Evanstion, IL (US) (2014)
Company Filing History:
Years Active: 2012-2014
Title: Richard William Carthew: Innovator in RNAi Research
Introduction
Richard William Carthew is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of RNA interference (RNAi) through his innovative research and patents. With a total of 2 patents, Carthew's work focuses on enhancing RNAi mechanisms, which have important implications in various scientific and therapeutic applications.
Latest Patents
Carthew's latest patents revolve around compositions and methods for altering RNAi. These inventions provide systems and methods for identifying regulators of RNAi, such as HPS1 and HPS4. The patents detail methods for inhibiting these regulators to enhance RNAi, as well as identifying inhibitors like small molecules, nucleic acids (e.g., siRNA), and antibodies. The applications of these inventions span research, therapeutic drug discovery, and clinical uses.
Career Highlights
Richard William Carthew is affiliated with Northwestern University, where he continues to advance his research in RNAi. His work has garnered attention for its potential to impact functional genomics and drug delivery systems. Carthew's innovative approach to RNAi regulation positions him as a key figure in the field.
Collaborations
Some of Carthew's notable coworkers include Young Sik Lee and Dinari Harris. Their collaborative efforts contribute to the ongoing research and development in RNAi technologies.
Conclusion
Richard William Carthew's contributions to RNAi research through his patents and collaborations highlight his role as an influential inventor in the scientific community. His work continues to pave the way for advancements in therapeutic applications and functional genomics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
